Related Experiment Video
Updated: Jul 5, 2025

08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
13.9K
Long-Term Effect of Maintenance Electroconvulsive Therapy in Patients With Depression-Data From a Small Randomized
Ole Brus1, Yang Cao1, Andreas Carlborg2
1From the Clinical epidemiology and biostatistics, Faculty of Medicine and Health, Örebro University, Örebro.
The Journal of ECT
|January 17, 2024
Summary
Maintenance electroconvulsive therapy (M-ECT) with medication appears to maintain benefits long-term for depression relapse. However, small sample sizes limit certainty, necessitating further research on M-ECT efficacy.
Area of Science:
- Psychiatry
- Neurology
- Clinical Trials
Background:
- Depression relapse remains a significant challenge despite available treatments.
- Maintenance electroconvulsive therapy (M-ECT) has shown short-term efficacy in preventing depressive episodes.
- Long-term comparative data on M-ECT versus medication-only is limited.
Purpose of the Study:
- To compare the long-term effects of maintenance electroconvulsive therapy (M-ECT) plus medication versus medication alone in patients with depression.
- To assess relapse and recurrence rates over an extended follow-up period after initial M-ECT treatment.
Main Methods:
- A randomized controlled trial initially comparing 1 year of M-ECT with medication versus medication only.
- Long-term follow-up (up to 10 years) using Swedish national registers after M-ECT cessation.
- Kaplan-Meier estimates used to compare time to relapse between groups.
Main Results:
- Median follow-up was 6.5 years for M-ECT plus medication group and 3.1 years for medication-only group.
- Relapse patterns appeared similar between groups after M-ECT completion upon visual inspection.
- Initial 1-year results showed a significant advantage for M-ECT with medication.
Conclusions:
- Long-term benefits of M-ECT for depression may be sustained after treatment cessation.
- The study's small sample size and statistical imprecision limit definitive conclusions.
- Further long-term studies are needed to confirm the sustained efficacy of M-ECT.
Related Concept Videos
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237

